UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prognostic value of pre-treatment risk stratification and post-treatment neutrophil/lymphocyte ratio change for pembrolizumab in patients with advanced urothelial carcinoma

International journal of clinical oncology, 2021, Vol.26 (1), p.169-177

2021

Volltextzugriff (PDF)

Transperitoneal versus retroperitoneal laparoscopic adrenalectomy for large pheochromocytoma: Comparative outcomes

International journal of urology, 2019-02, Vol.26 (2), p.212-216

2019

Volltextzugriff (PDF)

Predictive factor of recurrence after endoscopic papillectomy for ampullary neoplasms

Journal of hepato-biliary-pancreatic sciences, 2021-07, Vol.28 (7), p.625-634

2021

Volltextzugriff (PDF)

Prognostic value of risk stratification using blood parameters for nivolumab in Japanese patients with metastatic renal-cell carcinoma

Japanese journal of clinical oncology, 2020-02, Vol.50 (2), p.214-220

2020

Volltextzugriff (PDF)

Impact of variant histology on disease aggressiveness and outcome after nephroureterectomy in Japanese patients with upper tract urothelial carcinoma

International journal of clinical oncology, 2015-04, Vol.20 (2), p.362-368

2015

Volltextzugriff (PDF)

From Viewpoint of ME Manufacturer

Transactions of Japanese Society for Medical and Biological Engineering, 2005, Vol.43(4), pp.505-507

OBA, Kazuo

2005

Volltextzugriff (PDF)

Prognostic risk score and index including the platelet-to-lymphocyte ratio and lactate dehydrogenase in patients with metastatic or unresectable urothelial carcinoma treated with immune checkpoint inhibitors

Japanese journal of clinical oncology, 2024-10

2024

Volltextzugriff (PDF)

Comparative Efficacy of Avelumab Maintenance Therapy Versus Continued Chemotherapy Followed by Pembrolizumab in Metastatic Urothelial Carcinoma With No Progression After 4 Cycles of Chemotherapy: A Retrospective Study Using Propensity Score Matching

Clinical genitourinary cancer, 2024-12, Vol.22 (6), p.102212, Article 102212

2024

Volltextzugriff (PDF)

Deletions on Chromosome 8p22 May Predict Disease Progression As Well As Pathological Staging in Prostate Cancer

Clinical cancer research, 2001-10, Vol.7 (10), p.3139-3143

2001

Volltextzugriff (PDF)

Prognostic value of risk stratification using blood biochemical parameters in Japanese patients with metastatic renal cell carcinoma treated by nivolumab

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.724-724

2020

Volltextzugriff (PDF)

A New Fossil Rorqual Aff. Balaenoptera Bertae Specimen from the Shinazawa Formation (Late Pliocene to Early Pleistocene), Yamagata, Japan

Paleontological research, 2023-07, Vol.27 (3)

2023

Volltextzugriff (PDF)

Risk group stratification to predict recurrence after transurethral resection in Japanese patients with stage Ta and T1 bladder tumours: validation study on the European Association of Urology guidelines

BJU international, 2011-05, Vol.107 (10), p.1598-1604

2011

Volltextzugriff (PDF)

Oral etoposide following combination chemotherapy and radiation therapy in a patient with advanced adult neuroblastoma led to long survival

International journal of clinical oncology, 2001-10, Vol.6 (5), p.259-261

2001

Volltextzugriff (PDF)

764: Clinical Significance of Association of Allelic Loss of Chromosome 3P25 with Alterations of Chromosome 5Q22.3-Q23.2 in Conventional Renal Cell Carcinoma

The Journal of urology, 2004-04, Vol.171 (4), p.203-203

2004

Volltextzugriff (PDF)

医療機器メーカの立場から

生体医工学, 2005, Vol.43(4), pp.505-507

大庭, 和夫

2005

Volltextzugriff (PDF)

Clinical significance of allelic loss of chromosome region 5q22.3∼q23.2 in nonpapillary renal cell carcinoma

Cancer genetics and cytogenetics, 2002-07, Vol.136 (1), p.23-30

2002

Volltextzugriff (PDF)

Numerical aberrations of chromosome 9 in bladder cancer

Cancer genetics and cytogenetics, 2002-04, Vol.134 (1), p.41-45

2002

Volltextzugriff (PDF)

New assay for staging and prognostic information in prostate cancer

Current opinion in urology, 1997-09, Vol.7 (5), p.263-267

1997

Volltextzugriff (PDF)

Transitional Cell Carcinoma of the Renal Pelvis with Vena Caval Tumor Thrombus

International journal of urology, 1997-05, Vol.4 (3), p.307-310

1997

Volltextzugriff (PDF)

Analysis of genomic alterations on urological malignancies by fluorescence in situ hybridization

Bulletin of the Yamaguchi Medical School, 2003-12, Vol.50, p.11

2003

Volltextzugriff (PDF)

Allelic loss of 3p25 associated with alterations of 5q22.3∼q23.2 may affect the prognosis of conventional renal cell carcinoma

Cancer genetics and cytogenetics, 2005-07, Vol.160 (1), p.43-48

2005

Volltextzugriff (PDF)

Haploinsufficiency of 8p22 may influence cancer-specific survival in prostate cancer

Cancer genetics and cytogenetics, 2007-04, Vol.174 (1), p.24-34

2007

Volltextzugriff (PDF)

Two putative tumor suppressor genes on chromosome arm 8p may play different roles in prostate cancer

Cancer genetics and cytogenetics, 2001, Vol.124 (1), p.20-26

2001

Volltextzugriff (PDF)

Numerical aberrations of chromosome 9 in bladder cancer.: A possible prognostic marker for early tumor recurrence

Cancer genetics and cytogenetics, 2002-04, Vol.134 (1), p.41-45

2002

Volltextzugriff (PDF)

Allelic loss of 3p25 associated with alterations of 5q22.3 approximately q23.2 may affect the prognosis of conventional renal cell carcinoma

Cancer genetics and cytogenetics, 2005-07, Vol.160 (1), p.43-48

2005

Volltextzugriff (PDF)

1 – 25 von 151

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(134)

Publikationsform

Sprache

Englisch
(120)
Japanisch
(49)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Prognostic value of pre-treatment risk stratification and post-treatment neutrophil/lymphocyte ratio change for pembrolizumab in patients with advanced urothelial carcinoma

Transperitoneal versus retroperitoneal laparoscopic adrenalectomy for large pheochromocytoma: Comparative outcomes

Predictive factor of recurrence after endoscopic papillectomy for ampullary neoplasms

Prognostic value of risk stratification using blood parameters for nivolumab in Japanese patients with metastatic renal-cell carcinoma

Impact of variant histology on disease aggressiveness and outcome after nephroureterectomy in Japanese patients with upper tract urothelial carcinoma

From Viewpoint of ME Manufacturer

Prognostic risk score and index including the platelet-to-lymphocyte ratio and lactate dehydrogenase in patients with metastatic or unresectable urothelial carcinoma treated with immune checkpoint inhibitors

Comparative Efficacy of Avelumab Maintenance Therapy Versus Continued Chemotherapy Followed by Pembrolizumab in Metastatic Urothelial Carcinoma With No Progression After 4 Cycles of Chemotherapy: A Retrospective Study Using Propensity Score Matching

Deletions on Chromosome 8p22 May Predict Disease Progression As Well As Pathological Staging in Prostate Cancer

Prognostic value of risk stratification using blood biochemical parameters in Japanese patients with metastatic renal cell carcinoma treated by nivolumab

A New Fossil Rorqual Aff. Balaenoptera Bertae Specimen from the Shinazawa Formation (Late Pliocene to Early Pleistocene), Yamagata, Japan

Risk group stratification to predict recurrence after transurethral resection in Japanese patients with stage Ta and T1 bladder tumours: validation study on the European Association of Urology guidelines

Oral etoposide following combination chemotherapy and radiation therapy in a patient with advanced adult neuroblastoma led to long survival

764: Clinical Significance of Association of Allelic Loss of Chromosome 3P25 with Alterations of Chromosome 5Q22.3-Q23.2 in Conventional Renal Cell Carcinoma

医療機器メーカの立場から

Clinical significance of allelic loss of chromosome region 5q22.3∼q23.2 in nonpapillary renal cell carcinoma

Numerical aberrations of chromosome 9 in bladder cancer

New assay for staging and prognostic information in prostate cancer

Transitional Cell Carcinoma of the Renal Pelvis with Vena Caval Tumor Thrombus

Analysis of genomic alterations on urological malignancies by fluorescence in situ hybridization

Allelic loss of 3p25 associated with alterations of 5q22.3∼q23.2 may affect the prognosis of conventional renal cell carcinoma

Haploinsufficiency of 8p22 may influence cancer-specific survival in prostate cancer

Two putative tumor suppressor genes on chromosome arm 8p may play different roles in prostate cancer

Numerical aberrations of chromosome 9 in bladder cancer.: A possible prognostic marker for early tumor recurrence

Allelic loss of 3p25 associated with alterations of 5q22.3 approximately q23.2 may affect the prognosis of conventional renal cell carcinoma

Suchergebnisse filtern